NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

LLY

Lilly(Eli) & Co

Apr 17 • 04:00PM ET

839.96

Dollar change +105.06
Percentage change 14.30	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO VUG IVV SPY XLV VIG IWF VHT QUAL

Scroll to Statements

Index	S&P 500	P/E	73.11	EPS (ttm)	11.49	Insider Own	10.34%	Shs Outstand	947.54M	Perf Week	16.51%
Market Cap	796.27B	Forward P/E	28.23	EPS next Y	29.76	Insider Trans	-0.89%	Shs Float	849.99M	Perf Month	0.35%
Income	10.59B	PEG	1.74	EPS next Q	4.05	Inst Own	72.97%	Short Float	0.83%	Perf Quarter	10.87%
Sales	45.04B	P/S	17.68	EPS this Y	76.67%	Inst Trans	-5.51%	Short Ratio	1.93	Perf Half Y	-8.03%
Book/sh	14.98	P/B	56.08	EPS next Y	29.67%	ROA	14.84%	Short Interest	7.02M	Perf Year	12.48%
Cash/sh	3.61	P/C	232.61	EPS next 5Y	41.96%	ROE	84.84%	52W Range	677.09 - 972.53	Perf YTD	8.80%
Dividend Est.	6.61 (0.79%)	P/FCF	211.77	EPS past 5Y	18.77%	ROI	24.79%	52W High	-13.63%	Beta	0.54
Dividend TTM	5.40 (0.64%)	Quick Ratio	0.89	Sales past 5Y	15.54%	Gross Margin	81.31%	52W Low	24.05%	ATR (14)	39.31
Dividend Ex-Date	Feb 14, 2025	Current Ratio	1.15	EPS Y/Y TTM	102.18%	Oper. Margin	37.83%	RSI (14)	57.94	Volatility	3.88% 4.15%
Employees	47000	Debt/Eq	2.37	Sales Y/Y TTM	32.00%	Profit Margin	23.51%	Recom	1.34	Target Price	1022.76
Option/Short	Yes / Yes	LT Debt/Eq	2.01	EPS Q/Q	101.79%	Payout	44.39%	Rel Volume	2.98	Prev Close	734.90
Sales Surprise	0.44%	EPS Surprise	5.45%	Sales Q/Q	44.68%	Earnings	May 01 BMO	Avg Volume	3.64M	Price	839.96
SMA20	6.69%	SMA50	0.51%	SMA200	-0.85%	Trades		Volume	10,832,820	Change	14.30%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363

Show Previous Ratings

Today 04:29PM	How Eli Lilly's GLP-1 pill could transform the weight-loss space (Yahoo Finance Video) +14.30%
04:10PM	Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill (Investor's Business Daily)
03:02PM	Stocks Claw Back Losses as Trump Goes on Offensive: Markets Wrap (Bloomberg)
02:41PM	Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race (Investing.com)
02:27PM	Lillys First Pill for Diabetes, Weight Loss Shows Positive Study Results (The Wall Street Journal)
02:24PM	Loading…
02:24PM	UnitedHealth Woes Arent Dragging Down the Entire Sector. Heres Why. (Barrons.com)
02:17PM	These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth (Investor's Business Daily)
02:01PM	Eli Lilly Stock Soars on Weight-Loss News. Why Its Bad for Novo Nordisk. (Barrons.com)
01:54PM	Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade (Investopedia)
01:45PM	Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results (Seeking Alpha)
12:55PM	Lilly Soars as Study Positions Weight-Loss Pill to Pass Ozempic (Bloomberg)
12:46PM	Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide (Motley Fool)
12:45PM	Top Stock Movers Now: UnitedHealth, Nvidia, Eli Lilly and More (Investopedia)
12:17PM	Eli Lillys shares up as oral GLP-1RA scores in first Phase III trial (Clinical Trials Arena)
12:01PM	Why Is Eli Lilly (LLY) Stock Rocketing Higher Today (StockStory)
11:36AM	Loading…
11:36AM	Wall Street Lunch: Obesity Pill Progress (Seeking Alpha)
11:20AM	Eli Lilly's weight loss pill could be just as good as Ozempic and the stock soars (Quartz)
11:15AM	UnitedHealth tumbles, Eli Lilly climbs, TSMC holds outlook (Yahoo Finance Video)
11:07AM	Scholar Rock: Apitegromab Approval And Obesity Shot Make For Rating Upgrade (Seeking Alpha)
11:04AM	Lilly reports positive phase 3 trial results for GLP-1 pill (CNBC TV)
11:03AM	Eli Lilly Stock Soars After Weight-Loss Pill Trial. Why Its Bad News for Novo Nordisk. (Barrons.com)
10:58AM	Eli Lilly and Company (LLY): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
10:54AM	Eli Lilly Soars as Oral Diabetes Pill Hits Targets in Phase 3 (GuruFocus.com)
10:39AM	Eli Lilly Shares Soar After Phase 3 Trial Success for Oral Type 2 Diabetes Pill (GuruFocus.com)
10:18AM	Eli Lilly stock soars on positive weight-loss pill results (Yahoo Finance Video)
10:18AM	Eli Lilly Stock Soars. Why a Weight-Loss Pill Trial Is Giving It a Boost. (Barrons.com)
10:12AM	Health Insurance Stocks Drop After UnitedHealth Forecast News (Investopedia)
10:07AM	Novo Nordisk shares slump following Eli Lillys weight-loss pill success (Investing.com)
10:00AM	Lilly confirms date and conference call for first-quarter 2025 financial results announcement (PR Newswire)
09:05AM	Lilly's Weight-Loss Pill Shocks Wall Street (GuruFocus.com)
09:00AM	Loading…
09:00AM	Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results (Investopedia)
08:34AM	Eli Lilly Stock Rockets On Weight-Loss Pill Progress (Investor's Business Daily)
08:20AM	Why Eli Lilly and Company (LLY) Is Among the Best Blue Chip Stocks to Buy According to Billionaires (Insider Monkey)
08:03AM	Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients (CNBC TV)
07:46AM	Eli Lilly shares jump 12% on positive Phase 3 results for oral diabetes drug (Investing.com)
06:50AM	Lilly's pill helps diabetes patients lose 7.9% weight in crucial study (Reuters)
06:45AM	Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch (Benzinga)
06:45AM	Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial (PR Newswire)
Apr-16-25 04:27PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
11:49AM	Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi (Zacks)
11:48AM	Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (Seeking Alpha)
10:56AM	Verve Therapeutics: FDA Fast Track And Eli Lilly Partnership Upgrade It To A 'Buy' (Seeking Alpha)
10:39AM	The GLP-1 drug shortage is over. Whats next for the compounders? (Pharmaceutical Technology)
10:33AM	Viking Therapeutics Stock Pops But Struggles to Hold Gains (MarketBeat)
07:05AM	Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip? (Zacks)
06:03AM	Analysis: Pharma companies expected to absorb any tariff hit in short term (Reuters)
Apr-15-25 05:45PM	Eli Lilly (LLY) Gains As Market Dips: What You Should Know (Zacks)
04:21PM	Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market (Seeking Alpha)
02:37PM	Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (Seeking Alpha)
01:36PM	Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy for Long Term Growth? (Insider Monkey)
12:57PM	Pfizer Halts Obesity Pill Development Amid Safety Concerns (Zacks)
12:27PM	VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study (Zacks)
10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
10:35AM	Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill (TipRanks)
10:00AM	NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback (Zacks)
08:08AM	Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke (TipRanks)
07:48AM	Eli Lilly and Company (LLY): One of the High Growth Forever Dividend Stocks to Invest In (Insider Monkey)
07:15AM	PepsiCo's Valuation Hasn't Been This Low In A Decade - Time To Buy (Seeking Alpha)
05:39AM	Tariff wars to hit popular US-made drugs in China, regulator data shows (Reuters)
Apr-14-25 11:32PM	Trump Initiates Chips and Drug Probes Ahead of More Tariffs (Bloomberg)
04:12PM	Verves shares jump by more than 26% on Lilly-partnered gene therapy data (Pharmaceutical Technology)
03:55PM	Stocks to Watch Monday: Apple, Palantir, Intel, Pfizer (The Wall Street Journal)
03:49PM	Eli Lilly's Mounjaro launch in India ignites wave of weight-loss enquiries (Reuters)
02:09PM	Aristotle Large Cap Growth Q1 2025 Commentary (Seeking Alpha)
01:27PM	This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. (Barrons.com)
01:13PM	Pharmaceutical Tariffs Coming Soon (Barrons.com)
11:12AM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today (Motley Fool)
10:55AM	Pfizer just had a big setback in its race for an Ozempic competitor (Quartz)
10:39AM	Jim Cramer on Eli Lilly and Company (LLY): "The Fastest Factory I've Ever Seen" (Insider Monkey)
10:37AM	ABBV vs. MRK: Which Drug Giant is a Better Buy Now? (Zacks)
10:13AM	Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury' (Investopedia)
09:53AM	Pfizer discontinues GLP-1 pill trial, stock trades flat (Yahoo Finance)
Apr-13-25 02:23PM	PFM: Dividend Growth ETF With High Fees And Average Result (Seeking Alpha)
08:44AM	Eli Lilly: Still Great, But Still Too Expensive Even As Earnings Near (Seeking Alpha)
Apr-12-25 10:26AM	Schrodinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade) (Seeking Alpha)
Apr-11-25 07:29PM	Apple Stocks Resilience Means This Is an Opportunity, Says BofA. Plus, Meta, Occidental, and More. (Barrons.com)
04:11PM	Why Eli Lilly and Company (LLY) Is the Best Medical Stock to Buy According to Billionaires (Insider Monkey)
01:56PM	Eli Lilly Tries to Kill Custom Tirzepatide--But This Healthtech Rebel Isn't Backing Down (GuruFocus.com)
12:55PM	Novartis commits $23bn to US manufacturing amid tariff threats (Pharmaceutical Technology)
12:23PM	Novo Remade Denmark. Then Came the Stock Selloff. (Barrons.com)
11:57AM	FASB sets clock for derivatives rules update (CFO Dive)
11:38AM	Eli Lilly Challenges Custom Tirzepatide--But This Healthtech Startup Is Fighting Back (GuruFocus.com)
10:27AM	Zealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With Roche (The Wall Street Journal)
09:06AM	Wall Street Pulls Back on the Weight-Loss Drug Hype (Barrons.com)
06:53AM	The Zacks Analyst Blog Highlights Eli Lilly, American Express, Thermo Fisher, Steel Partners and Oil-Dri (Zacks)
05:30AM	How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs (The Wall Street Journal)
03:13AM	Pharmas US manufacturing moment: Where companies are making the biggest moves (Pharma Voice)
03:13AM	Pharmas manufacturing moment: Where companies are making the biggest moves (Pharma Voice)
12:30AM	Harbor International Compounders Fund Q4 2024 Commentary (Seeking Alpha)
12:30AM	Harbor International Compounders ETF Q4 2024 Commentary (Seeking Alpha)
12:30AM	Harbor Health Care ETF Q4 2024 Commentary (Seeking Alpha)
Apr-10-25 05:52PM	Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs (Investopedia)
05:43PM	Top Research Reports for Eli Lilly, American Express & Thermo Fisher (Zacks)
12:01PM	Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. (Investor's Business Daily)
11:13AM	Harbor Capital Factor U.S. Large Cap ETF Q4 2024 Commentary (Seeking Alpha)
10:39AM	Harbor Dividend Growth Leaders ETF Q4 2024 Commentary (Seeking Alpha)
09:44AM	Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? (Zacks)
08:54AM	Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs (Zacks)
08:10AM	Harbor Long-Term Growers ETF Q4 2024 Commentary (Seeking Alpha)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 14 '24	Sale	882.47	15,022	13,256,490	97,778,788	Jun 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 10 '24	Sale	860.78	75,510	64,997,274	97,793,810	Jun 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 07 '24	Sale	852.29	139,490	118,886,587	97,869,320	Jun 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 06 '24	Sale	837.82	179,617	150,485,878	98,008,810	Jun 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 05 '24	Sale	836.32	20,383	17,046,673	98,188,427	Jun 06 04:00 PM
Rau Diogo	EVP & CIDO	Jun 01 '24	Option Exercise	0.00	6,300	0	14,146	Jun 04 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Jun 03 '24	Sale	829.77	192,794	159,974,050	98,208,810	Jun 04 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Jun 03 '24	Sale	819.47	750	614,602	7,130	Jun 03 04:15 PM
Norton Johna	EVP, Global Quality	Jun 03 '24	Sale	819.38	7,056	5,781,545	25,428	Jun 03 04:14 PM
LILLY ENDOWMENT INC	10% Owner	May 31 '24	Sale	822.11	22,206	18,255,871	98,401,604	Jun 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 29 '24	Sale	811.04	130,385	105,747,975	98,423,810	May 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 28 '24	Sale	809.00	2,052	1,660,068	98,554,195	May 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 24 '24	Sale	809.21	92,563	74,902,998	98,556,247	May 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 23 '24	Sale	809.99	50,767	41,120,963	98,648,810	May 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 22 '24	Sale	804.18	12,974	10,433,483	98,699,577	May 23 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 21 '24	Sale	805.45	186,259	150,021,694	98,712,551	May 22 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience